News
 

The association between sleep and overall health and well-being has long been of interest to physicians, researchers, and the general public. At the highest level, a simple U-shaped association between total sleep time and mortality has been described from as early as 1964. Those who sleep approximately 7 hours are at the lowest point in the curve,...

Matrix metalloproteinases (MMP)-9 facilitates the migration of T-cells to central nervous system (CNS), while tissue inhibitor of metalloproteinases-1(TIMP-1) inhibits the function of MMP-9.

During the current COVID-19 pandemic, the infection risk for each individual is determining their ability to work, interact with their partners, children and parents. Many of us have changed our treatment practices for MS and related diseases out of fear of a potentially lethal infection, but what do we know about the risk of infection in a patient...

A new clinical research study by Dr. Marjan Rafiee and Dr. Taufik Valiante of the Krembil Brain Institute at Toronto Western Hospital, part of University Health Network, has found that a Mozart composition may reduce seizure frequency in patients with epilepsy.

The US Food and Drug Administration (FDA) has approved fenfluramine (Fintepla, Zogenix) oral solution, a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in children age 2 years and older.